IVERIC BIO
IVERIC bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The Company is currently developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases.
IVERIC BIO
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2007-01-01
Address:
Princeton, New Jersey, United States
Country:
United States
Website Url:
http://www.ivericbio.com
Total Employee:
51+
Status:
Active
Contact:
609.945.6050
Total Funding:
507.9 M USD
Technology used in webpage:
SPF SSL By Default Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail IPv6 Google Maps Contact Form 7 GoDaddy DNS
Similar Organizations
ALSP
ALSP Inc. (American Life Science Pharmaceuticals, Inc.), is a privately held company based in San Diego, California.
Athersys
Athersys is a biopharmaceutical company that discovers and develops therapeutic products to treat several disease indications.
Cavidi
Cavdi is a Swedish company that makes products for detecting HIV.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Entegrion
Entegrion is a life sciences company dedicated to providing innovative solutions.
Eyenovia
Eyenovia is a biopharmaceutical company that provides a portfolio of next generation topical eye treatments.
Forbius
Forbius is a biopharmaceutical company that develops and designs niotherapeutics for the treatment of fibrotic diseases and cancers.
Marinus Pharmaceuticals
Marinus Pharmaceuticals reformulates, develops, and commercializes drugs to treat neurological, psychiatric, and pain disorders.
PowerVision
PowerVision is a device company developing implantable intraocular lenses.
Vital Art and Science
Vital Art and Science is an ophthalmic medical device company that develops a home diagnostic system for patients with retinal diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Hercules Capital
Hercules Capital investment in Post-IPO Debt - IVERIC bio
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - IVERIC bio
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Post-IPO Equity - IVERIC bio
Novo Holdings
Novo Holdings investment in Post-IPO Equity - IVERIC bio
Novo Holdings
Novo Holdings investment in Private Equity Round - IVERIC bio
Sofinnova Investments
Sofinnova Investments investment in Venture Round - IVERIC bio
SV Health Investors
SV Health Investors investment in Series B - IVERIC bio
Novo Holdings
Novo Holdings investment in Series B - IVERIC bio
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series B - IVERIC bio
Clarus Ventures
Clarus Ventures investment in Series B - IVERIC bio
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-13 | Iveric Bio Appoints Tony Gibney as Executive Vice President and Chief Business and Strategy Officer |
Official Site Inspections
http://www.ivericbio.com Semrush global rank: 2.83 M Semrush visits lastest month: 5.71 K
- Host name: 13.90.34.38
- IP address: 13.90.34.38
- Location: Washington United States
- Latitude: 38.7095
- Longitude: -78.1539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 22747
More informations about "IVERIC bio"
Iveric Bio
Iveric Bio is now part of Astellas Pharma Inc. You will be automatically forwarded to the Astellas Homepage in 10 seconds.See details»
News | Astellas Pharma Inc.
Jul 11, 2023 Tokyo and Parsippany, New Jersey, July 11, 2023 - Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced that it has …See details»
Astellas Completes Acquisition of Iveric Bio - Jul 11, 2023
Jul 11, 2023 (3) Acquisition amount US$40 per share, approximately US$5.9 billion in the aggregate (Acquisition amount includes the full amount required to purchase all outstanding …See details»
Astellas Completes Acquisition of Iveric Bio - PR Newswire
Jul 11, 2023 TOKYO and PARSIPPANY, N.J. , July 11, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that it has …See details»
Astellas Enters into Definitive Agreement to Acquire Iveric Bio
Apr 30, 2023 For more information on the Company, please visit www.ivericbio.com. Cautionary Notice Regarding Forward-Looking Statements All statements in this press release, other than …See details»
Iveric Bio Announces FDA Accepts New Drug Application and …
Feb 16, 2023 Iveric Bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatments for retinal diseases with significant unmet …See details»
Astellas Enters Into Definitive Agreement to Acquire Iveric Bio
* Includes holdings of its subsidiaries and affiliates; based on information from Iveric Bio’s definitive proxy statement filed on April 5, 2023, with the SEC in connection with Iveric Bio’s …See details»
ACQUISITION OF IVERIC BIO - Astellas Pharma
May 1, 2023 3 Additional Information and Where to Find It In connection with the proposed acquisition, Iveric Bio will be filing documents with the SEC, including preliminary and definitive …See details»
IVERIC bio - Crunchbase Company Profile & Funding
IVERIC bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs.See details»
IVERIC bio, Inc. - AnnualReports.com
IVERIC bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs.See details»
IVERIC bio, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for IVERIC bio, Inc. of Parsippany, NJ. Get the latest business insights from Dun & Bradstreet.See details»
IVERIC bio Company Profile 2024: Valuation, Investors ... - PitchBook
IVERIC bio Inc is a biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs.See details»
IVERIC bio - Craft
IVERIC bio (formerly known as Ophthotech) is a biopharmaceutical company engaged in the discovery and development of treatment options for retinal diseases.See details»
Financial Information - Iveric Bio
Market Capitalization (Mil) $5,512.18: Shares Outstanding (Mil) 137.98: Shares Outstanding, Average (FY) (Mil) 121.04See details»
IVERIC bio (Nasdaq:ISEE) - Simply Wall St
Jul 12, 2023 ivericbio.com: IVERIC bio, Inc., a biopharmaceutical company, focuses on the discovery and development of novel treatments for retinal diseases with unmet medical needs. …See details»
Iveric Bio Reports First Quarter 2021 Operational Highlights and ...
May 5, 2021 Investor Contact: Iveric Bio Kathy Galante Senior Vice President, Investor Relations [email protected] 212-845-8231 or Media Contact: SmithSolve Alex Van …See details»
Iveric Bio Announces the Addition of Global Pharmaceutical …
Jan 6, 2022 Iveric Bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatments for retinal diseases with significant unmet medical needs.See details»
Astellas Enters into Definitive Agreement to Acquire Iveric Bio
Apr 30, 2023 For more information on the Company, please visit www.ivericbio.com. Cautionary Notice Regarding Forward-Looking StatementsAll statements in this press release, ...See details»
Iveric Bio Reports First Quarter 2022 Operational Highlights and ...
Iveric Bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatments for retinal diseases with significant unmet medical needs.See details»
The Open Secret Behind Iveric Bio’s Continued Success
With a lead pipeline asset in late-stage clinical development and an experienced management team advised by leading experts, Iveric Bio is on target to developing transformative therapies …See details»